932MO Nivolumab (NIVO) Plus Platinum-Doublet Chemotherapy (chemo) Versus Chemo As Neoadjuvant Treatment for Resectable Non-Small Cell Lung Cancer (NSCLC): Health-related Quality of Life (hrqol) Outcomes from CheckMate 816
ANNALS OF ONCOLOGY(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要